IPP Bureau
IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
By IPP Bureau - May 09, 2023
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Baxter to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion
By IPP Bureau - May 09, 2023
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Briefs: Krsnaa Diagnostics
By IPP Bureau - May 09, 2023
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
By IPP Bureau - May 09, 2023
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007
By IPP Bureau - May 08, 2023
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Galmed Pharmaceuticals forms partnership with OnKai
By IPP Bureau - May 08, 2023
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Wacker acquires Spain-based biotech firm ADL BioPharma
By IPP Bureau - May 08, 2023
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Lupin to acquire French pharmaceutical company Medisol
By IPP Bureau - May 07, 2023
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr
By IPP Bureau - May 07, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr
By IPP Bureau - May 07, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr
By IPP Bureau - May 06, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
Briefs: Dr. Reddy's Laboratories
By IPP Bureau - May 06, 2023
USFDA has issued Form 483 with one observation
CORONA Remedies collaborates with Ferring Pharmaceuticals to commercialize maternal health & urology products in India
By IPP Bureau - May 06, 2023
The collaboration between CORONA and Ferring will cater to patients across India
India is emerging as a favourable destination to conduct clinical trials: PwC-USAIC Report
By IPP Bureau - May 05, 2023
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
